Literature DB >> 6631444

Albumin and immunoglobulin in plasma and cerebrospinal fluid, and blood-cerebrospinal fluid barrier function in patients with dementia of Alzheimer type and multi-infarct dementia.

I Alafuzoff, R Adolfsson, G Bucht, B Winblad.   

Abstract

Plasma and cerebrospinal fluid (CSF) from 20 patients with Alzheimer's dementia or senile dementia of Alzheimer type (AD/SDAT), 23 with multi-infarct dementia (MID) and 16 controls were assayed for their content of immunoglobulins (Ig) and albumin (Alb). The concentrations of IgG and Alb were used to analyze the blood-CSF barrier function in the respective group. MID patients had significantly (P less than 0.001) elevated plasma IgG levels compared to controls and AD/SDAT patients. CSF concentration of Alb was significantly higher in MID (P less than 0.01) and AD/SDAT (P less than 0.05) patients compared to the controls. Concentration of CSF IgG was significantly (P less than 0.05) lower in AD/SDAT patients compared to the MID patients; no significant differences were found when CSF concentrations of IgG of demented patients were compared to controls. These findings may indicate a blood-CSF barrier dysfunction especially in cases with MID with significantly (P less than 0.001) elevated values of transudation. Also these findings indicate a non-specific and/or specific binding of IgG in CNS tissue and/or vessel walls in both forms of dementia on the basis of low IgG ratios compared to proportionally higher Alb ratios. There were no signs of local synthesis of IgG in CNS in either group of demented patients.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6631444     DOI: 10.1016/0022-510x(83)90157-0

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  33 in total

1.  Alzheimer's disease and the Blood-Brain Barrier: Past, Present and Future.

Authors:  Gene L Bowman; Joseph F Quinn
Journal:  Aging health       Date:  2008-02-01

2.  Locus Coeruleus Degeneration Induces Forebrain Vascular Pathology in a Transgenic Rat Model of Alzheimer's Disease.

Authors:  Sarah C Kelly; Erin C McKay; John S Beck; Timothy J Collier; Anne M Dorrance; Scott E Counts
Journal:  J Alzheimers Dis       Date:  2019       Impact factor: 4.472

Review 3.  Drug delivery to the brain in Alzheimer's disease: consideration of the blood-brain barrier.

Authors:  William A Banks
Journal:  Adv Drug Deliv Rev       Date:  2011-12-17       Impact factor: 15.470

4.  Isolated blood-cerebrospinal fluid barrier dysfunction: prevalence and associated diseases.

Authors:  J Brettschneider; A Claus; J Kassubek; H Tumani
Journal:  J Neurol       Date:  2005-04-01       Impact factor: 4.849

5.  Perivascular deposits of serum proteins in cerebral cortex in vascular dementia.

Authors:  I Alafuzoff; R Adolfsson; I Grundke-Iqbal; B Winblad
Journal:  Acta Neuropathol       Date:  1985       Impact factor: 17.088

6.  In vivo two-photon microscopy reveals immediate microglial reaction to implantation of microelectrode through extension of processes.

Authors:  Takashi D Yoshida Kozai; Alberto L Vazquez; Cassandra L Weaver; Seong-Gi Kim; X Tracy Cui
Journal:  J Neural Eng       Date:  2012-10-17       Impact factor: 5.379

7.  Blood-brain barrier in Alzheimer dementia and in non-demented elderly. An immunocytochemical study.

Authors:  I Alafuzoff; R Adolfsson; I Grundke-Iqbal; B Winblad
Journal:  Acta Neuropathol       Date:  1987       Impact factor: 17.088

8.  Alzheimer's disease: paired helical filament immunoreactivity in cerebrospinal fluid.

Authors:  G P Wang; K Iqbal; G Bucht; B Winblad; H M Wisniewski; I Grundke-Iqbal
Journal:  Acta Neuropathol       Date:  1991       Impact factor: 17.088

9.  Effects of caspase-1 knockout on chronic neural recording quality and longevity: insight into cellular and molecular mechanisms of the reactive tissue response.

Authors:  Takashi D Y Kozai; Xia Li; Lance M Bodily; Ellen M Caparosa; Georgios A Zenonos; Diane L Carlisle; Robert M Friedlander; X Tracy Cui
Journal:  Biomaterials       Date:  2014-08-28       Impact factor: 12.479

10.  Effect of age and monosodium-L-glutamate (MSG) treatment on neurotransmitter content in brain regions from male Fischer-344 rats.

Authors:  D R Wallace; R Dawson
Journal:  Neurochem Res       Date:  1990-09       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.